Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Lane

Showing results (211-220 of 235) with videos related to

Pageof 24
Sort By:
Plos One|April 24, 2018
Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenibMarcus J G W Ladds, Andrés Pastor-Fernández, Gergana Popova, et al.
The Journal of Clinical Investigation|August 21, 2018
Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactiveMarton Keszei, Julien Record, Joanna S Kritikou, et al.
Nature Communications|August 18, 2022
Engineering an autonomous VH domain to modulate intracellular pathways and to interrogate the eIF4F complexYuri Frosi, Yen-Chu Lin, Jiang Shimin, et al.
Nature Methods|May 7, 2020
Combining native and 'omics' mass spectrometry to identify endogenous ligands bound to membrane proteinsJoseph Gault, Idlir Liko, Michael Landreh, et al.
The Journal of Clinical Investigation|December 1, 2021
Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactiveMarton Keszei, Julien Record, Joanna S Kritikou, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
De-risking Drug Discovery of Intracellular Targeting Peptides: Screening Strategies to Eliminate False-Positive HitsSimon Ng, Yu-Chi Juang, Arun Chandramohan, et al.
Cell Reports|July 16, 2020
A Patient-Derived Cell Atlas Informs Precision Targeting of GlioblastomaPatrik Johansson, Cecilia Krona, Soumi Kundu, et al.
Journal of Medicinal Chemistry|May 14, 2010
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.
Chemistry & Biology|November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.
Bioorganic & Medicinal Chemistry|March 31, 2018
Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challengesTomi K Sawyer, Anthony W Partridge, Hung Yi Kristal Kaan, et al.
Pageof 24

Showing results (211-220 of 235) with videos related to

Sort By:
Pageof 24
Plos One|April 24, 2018
Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenibMarcus J G W Ladds, Andrés Pastor-Fernández, Gergana Popova, et al.
The Journal of Clinical Investigation|August 21, 2018
Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactiveMarton Keszei, Julien Record, Joanna S Kritikou, et al.
Nature Communications|August 18, 2022
Engineering an autonomous VH domain to modulate intracellular pathways and to interrogate the eIF4F complexYuri Frosi, Yen-Chu Lin, Jiang Shimin, et al.
Nature Methods|May 7, 2020
Combining native and 'omics' mass spectrometry to identify endogenous ligands bound to membrane proteinsJoseph Gault, Idlir Liko, Michael Landreh, et al.
The Journal of Clinical Investigation|December 1, 2021
Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactiveMarton Keszei, Julien Record, Joanna S Kritikou, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
De-risking Drug Discovery of Intracellular Targeting Peptides: Screening Strategies to Eliminate False-Positive HitsSimon Ng, Yu-Chi Juang, Arun Chandramohan, et al.
Cell Reports|July 16, 2020
A Patient-Derived Cell Atlas Informs Precision Targeting of GlioblastomaPatrik Johansson, Cecilia Krona, Soumi Kundu, et al.
Journal of Medicinal Chemistry|May 14, 2010
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.
Chemistry & Biology|November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.
Bioorganic & Medicinal Chemistry|March 31, 2018
Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challengesTomi K Sawyer, Anthony W Partridge, Hung Yi Kristal Kaan, et al.
Pageof 24